Register entry
- Registered sites
- 0
- Active NDC listings
- 2
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
22 active NDC listings: 2 human prescription drug. By marketing category: BLA 1, NDA 1.
| Dosage form | NDCs |
|---|---|
| injection | 1 |
| injection, solution, concentrate | 1 |
| Route | NDCs |
|---|---|
| intraocular | 1 |
| intravenous | 1 |
| Labeller name on the listing | NDCs |
|---|---|
| omeros corporation | 2 |
Catalogue
Marketed products
2| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Omidria | phenylephrine and ketorolac | injection, solution, concentrate, intraocular | 62225-600NDA |
| YARTEMLEA | narsoplimab | injection, intravenous | 62225-300BLA |
Compare
Other companies listing narsoplimab
- Lonza Biologics Tuas Pte. Ltd.0 sites · 11 NDC
Enquiry
Common questions
- Is Omeros Corporation FDA approved?
- Omeros Corporation holds no registered establishment of its own; 2 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Omeros Corporation make?
- 2 products are listed under Omeros Corporation in the openFDA NDC Directory, most often as injection; injection, solution, concentrate. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.